Skip to main content
Premium Trial:

Request an Annual Quote

NCI to Spend $15 Million for New Integrative Cancer Biology Program

NEW YORK, Oct. 27 (GenomeWeb News) - The National Cancer Institute has provided $14.9 million to launch a new integrative cancer biology program that will use genomics, proteomics, and molecular-imaging technologies to generate computer and mathematical models that may be used in cancer prediction.

 

The program will tie together research from nine integrative biology centers in the field. These centers will design and validate models to simulate complex cancer processes. The centers also will serve as training and outreach programs, enabling developing technologies to be communicated to researchers in the cancer field, the NCI said in a statement today.

 

The centers and principal investigators in the program are Thomas Deisboeck of Massachusetts General Hospital; Todd Golub, Dana-Farber Cancer Institute; Joe Gray, Lawrence Berkeley National Laboratory; Tim H-M Huang, Ohio State University, Columbus; Richard Hynes, Massachusetts Institute of Technology; Timothy Kinsella, University Hospital of Cleveland; Joseph Nevins, Duke University; Sylvia Plevritis, Stanford University School of Medicine; Vito Quaranta, Vanderbilt University Medical Center, Nashville, Tenn.

 

The NCI's Cancer Biomedical Information Grid will coordinate all of the bioinformatics software needed by the program.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.